A. Topletz-Erickson

机构：Pfizer (United States)

发表论文 2 篇 · 总被引 1 次 · h-index 1

代表论文

• Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results (2026 · Nature Cancer · 被引 1)
• Abstract PS5-02-09: Unconjugated MMAE Pharmacokinetics in Combination with Tucatinib in Patients with HER2 Expressing Locally Advanced or Metastatic Breast and Gastric Cancer (2026 · Clinical Cancer Research)